Gene therapy based in antimicrobial peptides and proinflammatory cytokine prevents reactivation of experimental latent tuberculosis

Efficacy of gene-therapy based on adenovirus encoding granulocyte-macrophage colony-stimulating factor in drug-sensitive and drug-resistant experimental pulmonary tuberculosis

(2016) Alejandro Francisco-Cruz et al.   TUBERCULOSIS

Pneumococcal Adaptive Responses to Changing Host Environments

(2014) A. P. Hakansson   JOURNAL OF INFECTIOUS DISEASES

Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers

(2013) Cesar Enrique Rivas-Santiago et al.   Immunotherapy

Ability of Innate Defence Regulator Peptides IDR-1002, IDR-HH2 and IDR-1018 to Protect against Mycobacterium tuberculosis Infections in Animal Models

(2013) Bruno Rivas-Santiago et al.   PLoS One

Pattern Recognition Receptors and Cytokines inMycobacterium tuberculosisInfection—The Double-Edged Sword?

(2013) Md. Murad Hossain et al.   Biomed Research International

Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis

(2012) Bruno Rivas-Santiago et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Adjunct Immunotherapies for Tuberculosis

(2012) M. Uhlin et al.   JOURNAL OF INFECTIOUS DISEASES

Innate Immune Recognition ofMycobacterium tuberculosis

(2011) Johanneke Kleinnijenhuis et al.   Clinical & Developmental Immunology

Induction of β-defensins by l-isoleucine as novel immunotherapy in experimental murine tuberculosis

(2011) C. E. Rivas-Santiago et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis

(2010) J. Castañeda-Delgado et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Delivery of Therapeutic Proteins

(2010) Dipak S. Pisal et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

4 Months of Rifampin Compared with 9 Months of Isoniazid for the Management of Latent Tuberculosis Infection: A Meta‐analysis and Cost‐Effectiveness Study That Focuses on Compliance and Liver Toxicity

(2009) Panayiotis D. Ziakas et al.   CLINICAL INFECTIOUS DISEASES

Therapeutic Effect of Recombinant Adenovirus Encoding Interferon-γ in a Murine Model of Progressive Pulmonary Tuberculosis

(2008) Dulce A Mata-Espinosa et al.   MOLECULAR THERAPY

The Potential Role of Lung Epithelial Cells and β-defensins in Experimental Latent Tuberculosis

(2008) B. Rivas-Santiago et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY